Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Taiwan / NCT07342426
Recruiting Phase 4

High and Low Dose High-intensity Laser Therapy Lateral Epicondylitis

NCT07342426 · tracked via the Priya Life Science Taiwan tracker
Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Phase
Phase 4
Started
2026-01-12
Last updated
2026-01-21

Condition(s) studied

Lateral EpicondylitisHigh Intensity Laser TherapyTennis ElbowHigh Intensity Laser

Investigational drug(s) / intervention(s)

High intensity laser therapyInfarred ray therapy systemTranscutaneous electrical nerve stimulator

High intensity laser therapy: Using high-intensity laser therapy applying on the affected area.

Infarred ray therapy system: Using infarred ray therapy applying on affected area for 15 minutes.

Transcutaneous electrical nerve stimulator: Using transcutaneous electrical nerve stimulator on the affected area fior 15 minutes.

Study summary

High-intensity laser therapy has gained increasing attention in recent years as a therapeutic modality. It is a non-invasive treatment that can reduce pain, increase local blood circulation, and promote tissue repair. The higher energy output of high-intensity laser therapy also have deeper tissue penetration. Several studies have investigated the effects of high-intensity laser therapy on lateral epicondylitis, and the existing literature indicates that, compared with other treatment modalities, high-intensity laser therapy is more effective in improving pain and quality of life in patients with lateral epicondylitis.

However, the dosage, duration, and treatment frequency applied in previous studies vary considerably. The therapeutic effects of high-intensity laser therapy may therefore be influenced by treatment dosage. Consequently, the purpose of this study is to compare the effects of two different dosages of high-intensity laser therapy on patients with lateral epicondylitis.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Patients diagnosed with lateral epicondylitis by physician 2. Disease duration of less than three months 3. Adults aged above 18 years with full decision-making capacity Exclusion Criteria: 1. Patients who have received treatments other than standard treatment to the affected area within past three months 2. Patients with contraindication for rehabilitation therapy 1. Photosensitivity 2. Sensory impairment 3. Implanted cardiac pacemaker 4. Pregnancy 5. Malignancy 3. Patients with a history of surgery on the affected elbow 4. Patients with cervical radiculopathy

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
TSAI CHENG-TAO Physical Therapy Clinic Kaohsiung City Taiwan Recruiting

More Kaohsiung Medical University Chung-Ho Memorial Hospital trials in Taiwan

AKI Risk Factors Analysis After Intentional Hypotensive Anesthesia Recruiting
Bio-significance of LPC16:0 in Fibromyalgia Recruiting
Patient Experience of Older Adults Living Alone With Injuries Recruiting
Dignity Therapy for Older Adults in Long-term Care Institutions Recruiting
The Effect of Hydrogen Water in Oral Mucositis in Head and Neck Cancer Patients After Therapy Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07342426 on ClinicalTrials.gov ↗ ← All trials in Taiwan